Aprepitant Intravenous and Insulin Degludec (U-100) Prefilled Pens
Determining the interaction of Aprepitant Intravenous and Insulin Degludec (U-100) Prefilled Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant Intravenous-Insulin Degludec (U-100) Vials
- Aprepitant Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Aprepitant Intravenous-Insulin degludec and liraglutide
- Aprepitant Intravenous-Insulin degludec and liraglutide Subcutaneous
- Aprepitant Intravenous-Insulin degludec Subcutaneous
- Aprepitant Intravenous-Insulin detemir
- Insulin Degludec (U-100) Prefilled Pens-Aprepitant Oral Suspension
- Insulin Degludec (U-100) Prefilled Pens-Aprepitant/Fosaprepitant Dimeglumine
- Insulin Degludec (U-100) Prefilled Pens-Apresazide
- Insulin Degludec (U-100) Prefilled Pens-Apresoline
- Insulin Degludec (U-100) Prefilled Pens-Apresoline Injection
- Insulin Degludec (U-100) Prefilled Pens-Apri